Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

• 收藏
• 分享

专利权人:

Boehringer Ingelheim International GmbH

发明人:

Tillmann Taube,Dorothea Rudolph

申请号：

US14859422

公开号：

US09867831B2

申请日:

2015.09.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to the use of Volasertib or a salt thereof or the hydrate thereof in combination with Quizartinib or a salt thereof or the hydrate thereof for treating patients suffering from acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/